Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.07
- Piotroski Score 4.00
- Grade Neutral
- Symbol (INDT)
- Company INDUS Realty Trust, Inc.
- Price $66.99
- Changes Percentage (0.01%)
- Change $0.01
- Day Low $66.98
- Day High $67.01
- Year High $67.28
INDUS Realty Trust, Inc. is a real estate business principally engaged in developing, acquiring, managing and leasing industrial/warehouse properties. INDUS owns 41 buildings totaling approximately 4.6 million square feet (4.2 million of which is industrial/warehouse space) in Connecticut, Pennsylvania, North Carolina and Florida in addition to over 3,400 acres of undeveloped land.
- Last Earnings 06/12/2023
- Ex-Dividend for 5/16 Dividend 06/21/2023
- Dividend Payable 06/28/2023
- Today N/A
- Next Earnings (Estimated) 10/07/2020
- Fiscal Year End N/A
- Average Stock Price Target $81.00
- High Stock Price Target $81.00
- Low Stock Price Target $81.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.32
- Trailing P/E Ratio -209.34375
- Forward P/E Ratio -209.34375
- P/E Growth -209.34375
- Net Income $2.77 M
Income Statement
Quarterly
Annual
Latest News of INDT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure
Windtree Therapeutics announced positive Phase 2b results for istaroxime in treating cardiogenic shock. The study showed improvement in blood pressure and cardiac function over 96 hours, with promisin...
By Yahoo! Finance | 5 days ago -
WINT Stock Price | Windtree Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Windtree Therapeutics, Inc. is a biopharmaceutical company focusing on developing innovative treatments for acute cardiovascular and pulmonary diseases. Founded in 1992, it aims to address unmet medic...
By MarketWatch | 2 months ago -
Lindt's 2023 profit lifted by price hikes as chocolate market slows
(Reuters) -Lindt & Spruengli reported a rise in annual profit on Tuesday as the Swiss chocolate maker managed to pass on higher ingredients costs to customers while maintaining volumes amid a broa...
By Reuters | 6 months ago